Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Icardio.AI
AddedApr 14, 2024
UpdatedJul 4, 2026
Icardio.AI

Icardio.AI

Pre-Seed

Icardio.AI offers interpreting echocardiograms using machine learning algorithms.

Overview
Compare
Fundraising
Website

Icardio.AI, founded with the mission to revolutionize cardiovascular care through advanced technology, focuses on integrating artificial intelligence with cardiology. The company's vision is to enhance diagnostic accuracy and efficiency in cardiac health. Icardio.AI offers AI-assisted echocardiogram interpretations by top cardiologists and provides access to a vast collection of cardiovascular data for research and development projects. Their market focus includes healthcare providers, research institutions, and medical professionals seeking innovative solutions in cardiac diagnostics.

Notable affiliated individuals include leading cardiologists and AI experts who contribute to the development and refinement of their technology. Icardio.AI has achieved significant milestones in improving diagnostic precision and reducing interpretation times, positively impacting patient outcomes. Their AI-driven platform has garnered attention from both the medical community and investors interested in advancing healthcare technology. The overall impact of Icardio.AI lies in its potential to transform cardiovascular diagnostics, making them more accessible and reliable.

Icardio.AI - Similar Companies

Heartio logo

Heartio

heartio.ai

AccurKardia logo

AccurKardia

accurkardia.com

Cardiac Insight logo

Cardiac Insight

Epsilon Imaging logo

Epsilon Imaging

Qardian Labs logo

Qardian Labs

Cardiodiagnostics logo

Cardiodiagnostics

CardioWise logo

CardioWise

cardiowiseinc.com

Anumana logo

Anumana

anumana.net

Cardio Diagnostics Holdings logo

Cardio Diagnostics Holdings

HeartVista logo

HeartVista

InVision Medical Technology logo

InVision Medical Technology

PulseData logo

PulseData

pulsedata.io

AngioInsight logo

AngioInsight

angioinsight.com

Empallo logo

Empallo

empallo.com

CardioPhi logo

CardioPhi

Icardio.AI - Quick Facts

Who are Icardio.AI's competitors?

Companies similar to Icardio.AI include Heartio, AccurKardia, Cardiac Insight and Epsilon Imaging.

When was Icardio.AI's last funding round?

Icardio.AI's most recent funding round was for $20k (USD) in January 2023.

How much has Icardio.AI raised to-date?

As of Jan 1, 2023, Icardio.AI has raised a total of $20k (USD).

Icardio.AI - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Echocardiogram Analysis
Tags
  • AI Operations
  • Consulting
  • Data
  • Healthtech